Statins are highly effective in managing hypercholesterolaemia in patients with or without chronic heart disease due to extensive evidence for safety, efficacy and cost effectiveness. Observational cross sectional retrospective cohort study was done in approximately 200 primary care practices in Scotland. Frequency, rates and time trends for statin prescriptions together with demographic data and the prescribing patterns for high dose simvastatin and newer statins in its place was measured. 63%, 27%, 5%, 4% and 1% patients were prescribed simvastatin, atorvastatin, pravastatin, rosuvastatin and fluvastatin respectively (n=1,91370). Prevalence for individual statin as well as for all statin prescriptions, significantly increased (p<0.05). Ex...
Background: Cholesterol-lowering therapy with statins is recommended in established cardiovascular d...
Objective To compare the social and demographic profiles of patients who receive statin treatment af...
BackgroundThe current study evaluated time trends of statin use and incidence of recurrent CVD in se...
Statins are highly effective in managing hypercholesterolaemia in patients with or without chronic h...
Objective: Statins have been commonly used to treat patients with hypercholesterolaemia and to preve...
BACKGROUND: A previous study has shown that variations in threshold and intensity (lipid goal attain...
Aim: Statins have a proven role for the secondary prevention of cardiovascular disease. Despite this...
Background: Prescribing of lipid-lowering agents (LLAs) has increased worldwide including in Scotlan...
Objective: To compare the social and demographic profiles of patients who receive statin treatment a...
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Statins are widely used for the primary and secondary ...
What is already known about this subject • Use of statins is growing worldwide and costs represent a...
To examine HMG-CoA reductase inhibitor (statin) drug dispensing patterns to Nova Scotia Seniors' Pha...
Introduction Therapy with 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, or ...
Background: Cholesterol-lowering therapy with statins is recommended in established cardiovascular d...
Objective To compare the social and demographic profiles of patients who receive statin treatment af...
BackgroundThe current study evaluated time trends of statin use and incidence of recurrent CVD in se...
Statins are highly effective in managing hypercholesterolaemia in patients with or without chronic h...
Objective: Statins have been commonly used to treat patients with hypercholesterolaemia and to preve...
BACKGROUND: A previous study has shown that variations in threshold and intensity (lipid goal attain...
Aim: Statins have a proven role for the secondary prevention of cardiovascular disease. Despite this...
Background: Prescribing of lipid-lowering agents (LLAs) has increased worldwide including in Scotlan...
Objective: To compare the social and demographic profiles of patients who receive statin treatment a...
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Statins are widely used for the primary and secondary ...
What is already known about this subject • Use of statins is growing worldwide and costs represent a...
To examine HMG-CoA reductase inhibitor (statin) drug dispensing patterns to Nova Scotia Seniors' Pha...
Introduction Therapy with 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, or ...
Background: Cholesterol-lowering therapy with statins is recommended in established cardiovascular d...
Objective To compare the social and demographic profiles of patients who receive statin treatment af...
BackgroundThe current study evaluated time trends of statin use and incidence of recurrent CVD in se...